SBRA

SBRA Analyst Note Date: 2026-06-20 Ticker: SBRA (Sabra Health Care REIT, Inc.)

1. Structural Readiness

• Conservative Entry: $20.25
• Current Price: $18.12
• Extension: -10.5% vs. conservative entry

2. Thesis Layer

Thesis Classification: Tactical / Setup-Led Secular Exposure: None Named

As of 2026-06-20, SBRA carries no named secular thesis. The setup is purely tactical and driven by the technical structure of the coil. There is no macro or thematic overlay (e.g., "Silver Bullet," "Demographic Super-Cycle") attached to this specific trade signal at this date. Consequently, conviction must be derived strictly from the quality of the setup structure (which is currently failed) and the underlying business fundamentals. We do not invent a thesis to justify a trade; we judge the name on its setup quality and business health. Since the setup is invalidated, the tactical thesis is currently null.

3. Business Overview

Business Model: Sabra Health Care REIT, Inc. operates as a real estate investment trust (REIT) focused on the healthcare sector. Its primary business consists of acquiring, financing, and owning real estate properties leased to third-party tenants in the U.S. and Canada. The company generates revenue primarily through leasing properties to operators and owning properties managed by third-party property managers.

Portfolio Composition: As of the most recent filings (April 29, 2026), the investment portfolio is diversified across:

• Skilled nursing/transitional care facilities
• Senior housing communities (Leased and Managed)
• Behavioral health facilities
• Specialty hospitals
• Loans receivable and preferred equity investments

Operational Evidence (Source Date: 2026-04-30):

• Acquisition Activity: Management reported closing or being awarded $400 million year-to-date. Additionally, $107 million in managed senior housing and $94 million in skilled nursing investments were awarded, with most expected to close in the second quarter.
• Pipeline: The company is actively pursuing an additional $690 million of managed senior housing investments.
• Portfolio Growth: During the three months ended March 31, 2026, the company acquired three Senior Housing - Managed communities and one skilled nursing facility for $96.1 million.
• Operational Metrics:
• Same-Store SHOP NOI: Year-over-year growth was higher than the previous two quarters.
• Occupancy: First-quarter same-store occupancy rose 280 basis points year-over-year to 88.4%.
• Managed Portfolio: Sequential revenue growth of 7.2% and cash NOI growth of 9.5%, with margin expansion of 60 basis points.
• Payer Mix: For the first time in company history, private pay concentration reached 50% of the portfolio.
• Liquidity: As of December 31, 2025, the company held approximately $1.2 billion in liquidity, comprising $71.5 million in cash, $782.4 million in available revolver borrowings, and $322.7 million in forward sale agreements.

Risk Factors (Source Date: 2026-04-29): Management noted that operations are impacted by economic conditions, inflation, and volatility in public equity and fixed income markets, which have increased costs and limited capital availability. Lease agreements include CPI-based rent escalators ranging from 1.0% to 5.0%.

4. Archetype and Conviction

Archetype Candidate: Margin Inflector Fit Analysis: The "Margin Inflector" archetype fits the fundamental narrative presented in the Q1 2026 earnings data. The company is demonstrating a shift in portfolio quality (50% private pay) and operational efficiency (9.5% cash NOI growth, 60 bps margin expansion). The business is actively inflecting margins through managed senior housing growth and occupancy improvements.

Conviction Stack:

• Thesis Strength: Low. No named secular thesis; purely tactical.
• Evidence Quality: High. Strong operational data from Q1 2026 (occupancy, NOI, private pay mix) supports the business narrative.
• Structural Quality: Weak. The ATR at breakout (2.1%) was sub-threshold, indicating a lack of volatility-driven momentum at the setup origin.
• Rerating Potential: Unclear. While fundamentals show improvement, the technical structure is broken.

Valuation Context: No specific valuation multiples (P/FFO, EV/EBITDA) are provided in the evidence base for 2026. The focus remains on the structural invalidation of the setup.

5. Invalidating and Strengthening Factors

Invalidation:

Strengthening:

• Fundamental: Continued execution on the $690 million pipeline and sustained same-store NOI growth.

Evidence Gaps:

• Guidance Update: Management stated on April 30, 2026, that they would "reevaluate earnings guidance for the second quarter." As of June 20, 2026, the specific re-evaluated guidance figures are not provided in the evidence block.
• Capital Markets: While liquidity is strong ($1.2B), the specific impact of "increased volatility in public equity and fixed income markets" on the cost of capital for the $690M pipeline is not quantified in the provided text.

PRIVATE ANALYST CALL

Judgment: Sell Confidence: high Key risks: Fundamental deterioration in occupancy or NOI growth; inability to execute on the $690M pipeline due to capital market volatility; further compression of margins. Sizing hint: Zero position; invalidation protocol requires exit or avoidance. Expected horizon: Indefinite until structural invalidation is resolved via a new breakout. Failure mode to watch: A close below $17.07 that persists, confirming the breakdown of the support structure.